Lenskart Solutions Share price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 62,21,160 shares, with a market capitalization of ₹1738720607. Its Average Traded Price (ATP) is ₹661.09, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹655.95.
Lenskart Solutions has an upper circuit limit of ₹791.70 and a lower circuit limit of ₹527.80. The total value traded stands at ₹411.27 CR, and the delivery percentage for the day is 43.88%.
The stock is currently traded with a market lot size of 1. Lenskart Solutions also offers a dividend yield of 0%.
Lenskart Solutions share price chart
Lenskart Solutions Share Key Metrics
Volume
62.21 L
Market Cap
114051.38 CR
LTQ@LTP
1@655.95
ATP
661.09
Var Margin
13.99 %
Circuit Range
527.8-791.7
Delivery %
43.88 %
Value
411.27 CR
ASM/GSM
No
Market Lot
1
Lenskart Solutions Resistance and Support
Pivot 660.55
Resistance
First Resistance
673.1
Second Resistance
686.45
Third Resistance
699
Support
First Support
647.2
Second Support
634.65
Third Support
621.3
Lenskart Solutions Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-20 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-29 | Quarterly Results |
Lenskart Solutions News
Lenskart Solutions Ltd - 544600 - General Updates
Lenskart Solutions reported a cyber incident involving a sub-vendor for its Singapore business. The company confirmed no disruption to its operations or customers and stated the issue was promptly identified and remediated, with the regulator notified.
Aug 20 2026 22:57:19
Lenskart Solutions Ltd - 544600 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Lenskart Solutions announced the incorporation of Wenzhou Framekart Trade Co., Ltd. in China on August 14, 2026. This new step-down subsidiary will engage in trading, import, export, and procurement of spectacle frames and allied optical products, enhancing Lenskart's global supply chain and market reach.
Aug 17 2026 21:45:43
Lenskart Solutions Ltd - 544600 - Shareholders'' Letter And Results Dated August 12, 2026
Lenskart Solutions recorded strong Q1 FY27 results, with revenue up 33.6% to Rs.2,714 crore and net profit soaring 182.3% to Rs.228 crore. The company saw product margin cross 70% and significant growth in eye tests and new stores.
Aug 12 2026 15:53:32
Lenskart Solutions Ltd - 544600 - Board Meeting Outcome for Outcome Of Board Meeting
Lenskart's Board approved Q1 FY27 cons. financial results with revenue of ₹2,714.18 cr (up 43.27% YoY) and net profit of ₹228.43 cr (up 273.44% YoY). Also approved increasing stake in Baofeng Framekart Technology to 70% for ₹106 mn, and incorporating OWNDAYS Korea and Wenzhou Framekart Trade.
Aug 12 2026 15:41:08
Lenskart Solutions Ltd - 544600 - Update Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Incorporation Of Joint Venture Company "Lenskart Metalframes Private Limited"
Lenskart Solutions has incorporated a new joint venture company, Lenskart Metalframes Private Limited, with China's Mingfeng Glassesworld Limited (MGL). Lenskart will hold an 80% stake in the JVC, which aims to strengthen manufacturing capabilities and improve supply chain efficiency for metal spectacle frames.
Jul 30 2026 19:30:05
Lenskart Solutions Ltd - 544600 - Board Meeting Intimation for Intimation Of Board Meeting
Lenskart Solutions board to convene on August 12, 2026, to review and approve the financial results for the first quarter of FY27. This meeting will cover both standalone and consolidated unaudited results.
Jul 28 2026 15:37:41
Lenskart Solutions Management
| Name | Position |
|---|---|
| Peyush Bansal | Chairman, Managing Director & Chief Executive Officer |
| Neha Bansal | Executive Director |
Lenskart Solutions Similar Stocks
Sun Pharmaceutical Industries Ltd.
1922.00
12.00 (0.63%)
Divi's Laboratories Ltd.
8744.50
248.50 (2.92%)
Torrent Pharmaceuticals Ltd.
4932.00
45.50 (0.93%)
Apollo Hospitals Enterprise Ltd.
8889.00
187.00 (2.15%)
Cipla Ltd.
1422.00
-15.90 (1.11%)
Zydus Lifesciences Ltd.
1124.50
20.70 (1.88%)
Lupin Ltd.
2175.50
-12.50 (0.57%)
Dr. Reddy's Laboratories Ltd.
1193.50
3.50 (0.29%)
Mankind Pharma Ltd.
2365.00
-9.50 (0.40%)
Laurus Labs Ltd.
1866.20
65.20 (3.62%)
Lenskart Solutions FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in LENSKART
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC